ESSA Pharma Inc.

NasdaqCM:EPIX

Location

Market Cap

USD 75.02 M

Share Price

USD 1.69

Avg Daily Volume

162,368

Change (1 day)

0.00%

Change (1 year)

-63.73%

Change (YTD)

-5.59%

ESSA Pharma Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2025

ESSA Pharma Inc. EBITDA is NA for the Trailing 12 Months (TTM) ending March 31, 2025. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • ESSA Pharma Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2024 was USD -27.63 M, a -4.50% change year over year.
  • ESSA Pharma Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2023 was USD -28.93 M, a -22.06% change year over year.
  • ESSA Pharma Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2022 was USD -37.12 M, a 29.88% change year over year.
  • ESSA Pharma Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2021 was USD -28.58 M, a 59.64% change year over year.
Key data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)
Market news
Loading...
NasdaqCM: EPIX

ESSA Pharma Inc.

CEO Dr. David Ross Parkinson M.D.
IPO Date March 13, 2015
Location Canada
Headquarters 999 West Broadway
Employees 35
Sector 🏥 Health Care
Industries
Description

ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreements with Caris Life Sciences, Inc.; Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.

Similar companies

NOVO-B.CO

Novo Nordisk A/S

USD 75.07

1.29%

ABBV

AbbVie Inc.

USD 185.49

0.01%

RO.SW

Roche Holding AG

USD 338.56

1.02%

ABT

Abbott Laboratories

USD 132.41

0.10%

NOVN.SW

Novartis AG

USD 116.54

0.69%

AZN.L

AstraZeneca PLC

USD 142.38

0.60%

MRK

Merck & Co., Inc.

USD 79.29

1.29%

AMGN

Amgen Inc.

USD 289.63

-0.14%

BSX

Boston Scientific Corporation

USD 101.37

-0.35%

TMO

Thermo Fisher Scientific Inc.

USD 392.56

0.59%

PFE

Pfizer Inc.

USD 23.88

-0.50%

GILD

Gilead Sciences, Inc.

USD 108.00

0.00%

SAN.PA

Sanofi

USD 95.53

0.50%

VRTX

Vertex Pharmaceuticals Incorporated

USD 448.40

1.45%

BMY

Bristol-Myers Squibb Company

USD 46.84

-0.83%

4519.T

Chugai Pharmaceutical Co., Ltd.

USD 50.10

0.95%

GSK.L

GSK plc

USD 19.35

-0.49%

CSL.AX

CSL Limited

USD 156.33

0.91%

SHL.DE

Siemens Healthineers AG

USD 52.76

0.92%

REGN

Regeneron Pharmaceuticals, Inc.

USD 513.58

0.93%

MRK.DE

MERCK Kommanditgesellschaft auf Aktien

USD 125.22

-0.56%

207940.KS

Samsung Biologics Co.,Ltd.

USD 742.71

2.97%

BDX

Becton, Dickinson and Company

USD 168.59

-0.79%

600276.SS

Jiangsu Hengrui Medicine Co., Ltd.

USD 7.17

-0.44%

4502.T

Takeda Pharmaceutical Company Limited

USD 29.64

0.18%

ALNY

Alnylam Pharmaceuticals, Inc.

USD 312.32

1.17%

RGC

Regencell Bioscience Holdings Limited

USD 63.35

-18.78%

UCB.BR

UCB SA

USD 181.20

1.74%

A

Agilent Technologies, Inc.

USD 115.52

-0.49%

GEHC

GE HealthCare Technologies Inc.

USD 71.89

1.05%

BAYN.DE

Bayer AG

USD 30.95

-0.91%

068270.KS

Celltrion, Inc.

USD 118.94

2.83%

2359.HK

WuXi AppTec Co., Ltd.

USD 9.34

0.31%

22UA.F

BioNTech SE

USD 103.27

-1.03%

NTRA

Natera, Inc.

USD 170.98

2.05%

LH

Laboratory Corporation of America Holdings

USD 261.39

0.75%

3692.HK

Hansoh Pharmaceutical Group Company Limited

USD 3.54

0.04%

RPRX

Royalty Pharma plc

USD 34.91

1.01%

INSM

Insmed Incorporated

USD 99.46

-0.82%

BIIB

Biogen Inc.

USD 126.54

-0.02%

4503.T

Astellas Pharma Inc.

USD 9.35

0.21%

BIM.PA

bioMérieux S.A.

USD 136.66

0.21%

1801.HK

Innovent Biologics, Inc.

USD 9.71

-2.77%

BAX

Baxter International Inc.

USD 29.80

-0.40%

SMMT

Summit Therapeutics Inc.

USD 20.16

1.56%

196170.KQ

ALTEOGEN Inc.

USD 286.19

2.43%

4507.T

Shionogi & Co., Ltd.

USD 17.13

0.09%

ILMN

Illumina, Inc.

USD 90.26

0.88%

GMAB.CO

Genmab A/S

USD 215.49

-0.96%

StockViz Staff

June 21, 2025

Any question? Send us an email